WebDec 2, 2024 · The company strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases by tapping into the epigenome to program biology without altering the DNA sequence, providing patients with treatments for pervasive and complex diseases. Contact Information … WebChristina Trojel-Hansen, Ph.D. Name: Dr. Tamar Raz: Title: Chief Executive Officer : Title: CEO: Date: September 10, 2024 : Date: August 31, 2024: IN WITNESS WHEREOF, Oscine Therapeutics consents and agrees to the amendment of the Agreement as set forth herein and the termination of it as a party thereto.

Christina Trojel Hansen - Crunchbase Person Profile

WebApr 26, 2024 · Christina was named Endpoints 20 under 40 for 2024. She's a serial biotech entrepreneur who has been a driving force behind the creation of several new companies in the biotech space over the last few years. She studied at Copenhagen University and UC Berkeley before using her adept networking skills and 'Stay Hungry' attitude to break into … WebApr 26, 2024 · Episode 0009 with Dr. Christina Trojel-Hansen, Serial Biotech … here places

Dr. Christina Trojel-Hansen

WebChristina Trojel-Hansen Entrepreneur-in-residence. Dr. Christina Trojel-Hansen is co-founding CEO of a regenerative medicine newco being launched within the CRISPR gene correction space together with pioneers in hemopoietic stem cell gene therapy. Dr. Trojel previously co-founded and was CEO of Oscine Therapeutics, a CNS cell therapy firm that ... WebSchedule an appointment with Christina Trojel-Hansen, Ph.D. Please answer the … WebDiversity Spotlight (US Headquarters Only) Women Founded. Headquarters Regions Great Lakes, East Coast, Northeastern US. Founded Date 2024. Founders Christina Trojel Hansen. Operating Status Closed. Last Funding Type Seed. Company Type For Profit. Contact Email [email protected]. here platform